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Abstract
Background: Thymic stromal lymphopoietin (TSLP), an IL7-like cytokine produced by bronchial epithelial cells is
upregulated in asthma and induces dendritic cell maturation supporting a Th2 response. Environmental pollutants,
including tobacco smoke and diesel exhaust particles upregulate TSLP suggesting that TSLP may be an interface between
environmental pollution and immune responses in asthma. Since asthma is prevalent in urban communities, variants in the
TSLP gene may be important in asthma susceptibility in these populations.
Objectives: To determine whether genetic variants in TSLP are associated with asthma in an urban admixed population.
Methodology and Main Results: Ten tag-SNPs in the TSLP gene were analyzed for association with asthma using 387
clinically diagnosed asthmatic cases and 212 healthy controls from an urban admixed population. One SNP (rs1898671)
showed nominally significant association with asthma (odds ratio (OR)=1.50; 95% confidence interval (95% CI): 1.09–2.05,
p=0.01) after adjusting for age, BMI, income, education and population stratification. Association results were consistent
using two different approaches to adjust for population stratification. When stratified by smoking status, the same SNP
showed a significantly increased risk associated with asthma in ex-smokers (OR=2.00, 95% CI: 1.04–3.83, p=0.04) but not
significant in never-smokers (OR=1.34; 95% CI: 0.93–1.94, p=0.11). Haplotype-specific score test indicated that an elevated
risk for asthma was associated with a specific haplotype of TSLP involving SNP rs1898671 (OR=1.58, 95% CI: 1.10–2.27,
p=0.01). Association of this SNP with asthma was confirmed in an independent large population-based cohort consortium
study (OR=1.15, 95% CI: 1.07–1.23, p=0.0003) and the results stratified by smoking status were also validated (ex-smokers:
OR=1.21, 95% CI: 1.08–1.34, p=0.003; never-smokers: OR=1.06, 95% CI: 0.94–1.17, p=0.33).
Conclusions: Genetic variants in TSLP may contribute to asthma susceptibility in admixed urban populations with a gene
and environment interaction.
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Introduction
Environmental insults support an immune milieu that promotes
allergic asthma [1]. Epithelial cells, the first targets of inhaled
environmental insults such as pollution or tobacco smoke, produce
cytokines that modify T cell and inflammatory cell responses.
Genetic variants of these cytokines may contribute to the
susceptibility to asthma. Furthermore, epithelial cell-derived
cytokines may be candidate genes that participate in gene-
environmental interactions.
Thymic stromal lymphopoietin (TSLP) has been called a
‘‘master switch’’ of allergic inflammation at the epithelial cell
and dendritic cell interface [2]. A member of the IL-7 family of
cytokines, TSLP induces maturation of myeloid dendritic cells
(mDC) that support Th2 polarization and promotes maintenance
of the Th2 memory response [2,3,4]. TSLP-treated mDC induce
an inflammatory Th2 response that is associated with elevated IL-
5, IL-4, IL-13, and TNF-a but low IL-10 [2,5,6]. Regulatory T
cell function is also downregulated by TLSP [7], allowing a Th2
permissive microenvironment [2,4,8,9].
TSLP is expressed by human epithelial cells [2,10] and is
increased in asthmatic airways [7,11,12]. We have reported that
diesel exhaust particles (DEP) upregulate TSLP expression in
human bronchial epithelial cells in response to oxidative stress and
that this epithelial-cell derived TSLP induces the functional
maturation and Th2 polarization of dendritic cells (DC) [13,14].
Tobacco smoke extract also upregulates TSLP expression in the
murine lung and in smooth muscle [15,16]. Recently, TNF- a, IL-
4, IL-13, rhinovirus, and dsRNA have also been described to
upregulate TSLP in human bronchial epithelial cells [17]. Airway
epithelial cell expression of TSLP is both necessary and sufficient
for the development of airway inflammation in murine models of
antigen-induced asthma [18,19]. These findings reinforce the
potential importance of TSLP and its genetic components in
environmental-associated asthma.
The gene for TSLP is located on human chromosome 5q22,
near the gene cluster encoding Th-2 cytokines [20,21]. A sex
stratified analysis recently showed that a TSLP polymorphism
(rs2289276) was associated with cockroach-specific IgE in Costa
Rican females [22]. In a large Canadian population, a SNP
(rs1837253) 5.7 kb upstream of the TSLP transcription start site
was associated with asthma [23] and the association was replicated
in a large consortium study [24]. An additional SNP (rs10062929)
of the TSLP gene has been identified in association with
eosinophilic esophagitis [25].
Urban populations in the United States have high morbidity
and mortality from asthma and are highly exposed to ambient air
pollutants such as diesel exhaust, environmental tobacco smoke,
and indoor allergens such as those from cockroach [26]. These
populations are often of diverse racial and ethnic backgrounds,
and thus complex populations for genetic studies. Because of the
importance of TSLP as a target for environmental-associated
asthma, we examined the association of genetic variants of TSLP
with asthma in an admixed urban community using genetic
ancestral informative markers to control for population substruc-
ture. Furthermore, we validated the findings using independent
populations.
Materials and Methods
Study Population
Asthmatics and healthy controls were identified from the New
York University Bellevue Asthma Registry (NYUBAR) in New
York City. This registry was approved by the Institutional Review
Board of the New York University School of Medicine and all
cases and controls signed informed consent. Cases were referred to
the registry by the Bellevue Hospital Center Asthma Clinic and
local clinics. Controls were referred by asthma cases and by
enlisting individuals directly from the community and from other
programs within Bellevue Hospital Center. Subjects were excluded
if they were less than 18 years old, were current smokers or had a
history of .10 pack-year (p-y) tobacco use, had unstable cardiac
disease, uncontrolled hypertension, lung disease other than
asthma, or neuromuscular disease. Questionnaires and evaluations
were completed for all individuals and participants were
ascertained with a diagnosis of asthma by a definition modified
from the Collaborative Study on Genetics of Asthma [27]. Because
most cases were on medication, bronchial hyperresponsiveness
with methacholine challenge testing was not performed. The
diagnosis was further confirmed using the published algorithm of
Enright et al. [28]. To assemble the case-control study, cases and
controls were selected to be genetically unrelated with a case to
control ratio of approximately 2 to 1, resulting in 387 unrelated
asthmatics and 212 healthy controls.
A replication population included 6 population-based cohorts
that are part of the Analysis in Population-based Cohorts of
Asthma Traits (APCAT) consortium [29]. Asthma diagnosis in
these populations was based on physician diagnosed asthma.
Individuals with a diagnosis of COPD, chronic bronchitis, or other
lung diseases were excluded from the analysis. Cohorts included:
the Helsinki Birth Cohort (HBC: 123 cases, 1533 controls), Health
2000 (H2000: 153 cases, 1841 controls), Finrisk (160 cases, 1705
controls) (includes Finrisk 1992, 1997, 2002 and 2007), the North
Finnish Birth Cohort 1966 (NFBC66: 364 cases, 3502 controls),
Laseri (119 cases, 1844 controls), and the Framingham Heart
Study (FH: 797 cases, 6463 controls) for a total of 1716 cases and
16888 controls. All individuals in the studies provided informed
consent and all studies were conducted with the approval of the
local ethics committees or institutional review boards.
Allergy testing and Spirometry
Measurements of total serum IgE (total IgE) and allergen-
specific IgE for allergens considered significant for the Northeast-
ern United States were performed in a commercial laboratory for
the NYUBAR cohort (Pharmacia ImmunoCAP assay; Quest
Diagnostics; Teterboro, NJ). An allergen-specific IgE level .0.35
kilo-international units (kIU)/L was considered positive. Pre- and
post-bronchodilator spirometry was performed according to
American Thoracic Society guidelines [30] and normal values
were obtained from Hankinson et al. [31]. Individuals were on a
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medications were withheld for 6 hours prior to testing.
Candidate SNP selection and genotyping
Contiguous single nucleotide polymorphisms (SNPs) in the
TSLP region on chromosome 5q were identified in the
International Haplotype (HapMap) project (International Haplo-
type Consortium 2003) using data from the European Americans
(CEU) and the West African population (YRI). The program
Tagger [32] was used to select representative SNPs from the TSLP
gene with high linkage disequilibrium (LD) (minor allele frequency
.5% and r
2$0.8). Genotyping was performed at the Robert S.
Boas Center for Genomics and Human genetics on an Illumina
BeadStation 500G Golden Gate custom panel using unamplified
DNA extracted from blood. Genotyping reproducibility was
verified with duplicates. Ten SNPs in TSLP were successfully
genotyped with call rate greater than 99% and minor allele
frequency (MAF) greater than 1%. The genotypic information and
the Hardy-Weinberg analysis results are summarized in Table S1.
Genome-wide genotyping, quality control measures, and
imputation in the replication cohorts (APCAT) has been described
previously [29]. Briefly, each cohort was genotyped on a platform
containing .500,000 SNPs, and, after quality control the
genotypes at .2.2 million genotypes were imputed using the
HapMap CEU panel as a reference.
Ancestral informative markers (AIMs) with the maximal
absolute difference in allele frequency between ancestral popula-
tions were used to differentiate continental origins most likely to be
represented in the NYUBAR population including diverse
Hispanic ancestry [33]. We genotyped 213 AIMs to adjust for
population admixture in associate tests [34,35].
Statistical analysis
Genotype frequencies of each SNP were tested for the
concordance with Hardy-Weinberg equilibrium (HWE) using
Pearson’s chi-square test in the overall population and then in the
control population using R package HardyWeinberg (http://cran.
r-project.org/web/packages/HardyWeinberg/index.html). Two
approaches, the principal component analysis (PCA) method
[36] and the Bayesian STRUCTURE method (version 2.2.3) [37]
were implemented using 213 AIMs to adjust for population
stratification. Either the first five principal component scores from
the PCA approach or the posterior probabilities from the
STRUCTURE approach were included in the association analysis
as ancestry covariates to adjust for population stratification.
Single SNP association tests with asthma susceptibility assuming
an additive allelic effect were performed using the logistic
regression, including covariates of age, BMI, income, education
and ancestry covariates. Subgroup analyses stratified by smoking
status into ex-smokers and never-smokers were also conducted. To
test whether multiple genetic variants from the TSLP gene were
associated with asthma, haplotypes were reconstructed using the
EM algorithm [38] and the haplotype-specific association were
tested using the score test approach based on the generalized
linear model [39] using R package haplo.stats (http://cran.r-
project.org/web/packages/haplo.stats/index.html). All analyses
were performed using R 2.9.1.
For the APCAT cohorts, each study separately performed a
single marker association analysis assuming an additive allelic
model for the imputed data set consisting of ,2.2 million SNPs.
SNPs with low imputation quality (r
2,0.3 for MACH) were
removed from all studies. Each cohort was stratified into current-
smokers, ex-smokers and never-smokers, and the association
analysis was further performed within each stratum. The analysis
was performed using the logistic regression, adjusted for age,
gender and the first ten principal components, and accounting for
uncertainty at imputed genotypes. The GEE logistic regression test
of the GWAF package in R (http://cran.r-project.org/web/
packages/GWAF/) was used to correct for familial relatedness in
FHS. Test statistics from individual studies were corrected for
inflation using genomic control, and then combined using meta-
analysis by combining the regression coefficients and standard
errors from each study, implemented in METAL (http://www.
sph.umich.edu/csg/abecasis/Metal/index.html).
Results
Patient characteristics
A total of 387 unrelated asthmatic patients and 212 unrelated
healthy controls were included in the analysis of the NYUBAR
population. The demographic and clinical characteristics of the
study population are shown in Table 1. A majority of the cases and
controls were women and were never-smokers. The average age of
the cases was slightly but significantly higher than that of the
control group (40.1 vs. 36.1, p=0.0015) and the average BMI of
the cases was significantly higher than the control group (29.9 vs.
27.2, p,0.0001). The self-reported race/ethnicity also differed
between cases and controls (p=0.01). Consistent with a diagnosis
Table 1. Characteristics of NYUBAR case-control study.
Total Case Control p-value
(N=599) (N=387) (N=212)
Gender, N (%) 0.18
Female 409 (68.3) 272 (70.3) 137 (64.6)
Male 190 (31.7) 115 (29.7) 75 (35.4)
Age, Mean (SD) 38.7 (13.3) 40.1 (14.0) 36.1 (11.4) 0.0015
BMI, Mean (SD) 28.9 (7.0) 29.9 (7.4) 27.2 (5.7) ,0.0001
Income, N (%) ,0.0001
,$15,000 per year 203 (33.9) 157 (40.6) 46 (21.6)
$15,000 to $49,999 179 (29.9) 103 (26.6) 76 (35.8)
.=$50,000 134 (22.4) 66 (17.0) 68 (32.1)
NA 83 (13.9) 61 (15.8) 22 (10.3)
Education, Mean (SD) 13.4 (3.9) 12.7 (3.9) 14.6 (3.6) ,0.0001
Self-reported Race/Ethnicity,
N( % )
0.01
Hispanic 326 (54.4) 228 (58.9) 98 (46.2)
Non-Hispanic Black 118 (19.7) 68 (17.6) 50 (23.6)
Non-Hispanic White 155 (25.9) 91 (23.5) 64 (30.2)
Smoking Status, N (%) 0.29
Ex-smokers 158 (26.4) 108 (27.9) 50 (23.6)
Never-smokers 441 (73.6) 279 (72.1) 162 (76.4)
Spirometry
Pre-FEV1, % predicted 83.7 (16.9) 79.2 (17.6) 91.9 (11.8) ,0.0001
Pre-FVC, % predicted 88.5 (15.0) 86.1 (15.8) 92.9 (12.4) ,0.0001
FEV1/FVC 77.2 (8.9) 74.8 (9.6) 81.6 (5.1) ,0.0001
Total IgE (geo-mean) 81.9 108.7 49.0 ,0.0001
Atopic status, N (%) ,0.0001
No 184 (30.7) 89 (23.1) 95 (44.8)
Yes 414 (69.1) 297 (76.9) 117 (55.2)
doi:10.1371/journal.pone.0025099.t001
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controls, with reduced % of predicted FEV1, FVC and FEV1/
FVC in cases compared to controls. Cases had a significantly
higher total IgE and more cases were atopic.
Population stratification
The first and second principal components from the PCA using
213 AIMs were plotted in Figure 1 with self-reported race/
ethnicity information. The first principal component scores
showed good separation between the self-reported non-Hispanic
white group and the self-reported non-Hispanic black group, while
the principal component scores of self-reported Hispanic group
were in-between. The first five principal components counted for
more than 80% of variability of the ancestry markers. The
STRUCTURE method estimates the posterior probability that
each subject belongs to each underlying population for each
individual. When included as covariates to adjust population
stratification in the association tests, the STRUCTURE method
resulted in similar results to the PCA method and thus the
STRUCTURE results are not reported.
TSLP and asthma susceptibility
The results of association analysis of asthma and TSLP SNPs
are summarized in Table 2. One SNP (rs1898671) was nominally
associated with asthma susceptibility in the overall population after
adjusting for covariates and population stratification (OR=1.50,
95% CI: 1.09–2.05, p=0.01). However, the risk of asthma was
increased for this SNP when analyzed in the subgroup of ex-
smokers, (OR=2.00, 95% CI: 1.04–30.83, p=0.04). In the
subgroup of never-smokers, SNP rs1898671 did not show
significant association with the risk of asthma (OR=1.34, 95%
CI: 0.93–1.94, p=0.11).
Because of the suggestion of an association of SNP rs1898671
with asthma, we examined whether the association of this SNP
with asthma susceptibility could be replicated in the APCAT
cohorts that combined 6 cohorts with 1716 asthma cases and
16888 controls. Analysis of this large cohort revealed consistent
results with a positive association between rs1898671 and asthma
(OR=1.15, 95% CI: 1.07–1.23, p=0.0003). When stratified by
smoking history, the replication cohort validated the finding in the
NYU cohort that the SNP affected risk in ex-smokers (OR=1.21,
95% CI: 1.08–1.34, p=0.003), whereas no significant association
was found in never-smokers.
TSLP haplotype analysis
Reconstructed haplotypes with estimated frequencies of greater
than 5% are listed in Table 3 and the estimated haplotype-specific
OR with respect to the reference haplotype group (defined as the
group with highest frequency) and p-values are also reported. The
second most frequent haplotype (GAGGGCAAAG) had an
estimated frequency of 24% and showed a significant increased
risk with asthma after adjusting age, BMI and population
stratification (OR=1.58, 95% CI: 1.10–2.27, p=0.01).
Discussion
Asthma is prevalent in urban populations of mixed ancestry
with high rates of morbidity and mortality in these populations.
However, few genetic studies have used diverse urban populations
for study because of the complexities of analysis resulting from
admixture and mixed ancestry. Moreover, the interaction with
environmental exposures may modify asthma risk. TSLP is an
epithelial cell-derived cytokine in the IL-7 family that is
mechanistically implicated with asthma in numerous human and
animal models. Both ambient pollutants and tobacco smoke,
Figure 1. Scatter-plot of the first and second principal components. Scatter-plot of the first and second principal components calculated
from the genotypes of 213 AIMs. The first principal component scores showed good separation between the self-reported non-Hispanic white and
self-reported non-Hispanic black groups, while the principal component scores of self-reported Hispanic group were in-between.
doi:10.1371/journal.pone.0025099.g001
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[13,15]. We demonstrated that a SNP variant in TSLP is
associated with clinical asthma in an urban population when
adjusting for ancestry as well as additional covariates. Examination
of an additional large population-based consortium study
supported the association between this SNP and clinical asthma.
Associations were found to be stronger in those with tobacco
exposure. Haplotype analysis of TSLP also revealed an elevated
risk of asthma associated with one haplotype. In summary, these
data suggest that genetic variants in TSLP may influence asthma
risk in complex populations with an environmental interaction.
Our primary population of study was a diverse population and
population stratification can influence genetic variation
[40,41,42,43]. Indeed, we identified a difference in self-reported
race/ethnicity between our asthma cases and controls, suggesting
that ancestral differences needed to be accounted for. Moreover a
large number of our cases and controls self-reported as Hispanic, a
group with complex ancestral history [44]. Thus we accounted for
ancestry in our evaluation using SNPs that previously have been
associated with similar populations [35] and our results remained
consistent even after incorporating ancestry in our evaluation
using either of two separate analyses (PCA or STRUCTURE).
The rs1898671 SNP was significant for clinical asthma after
adjusting for ancestry and covariates. We did not compensate for
multiple testing in these analyses as we considered them discovery
testing to be replicated using independent large cohorts. The
persistence of significance even after adjustment reinforced the
potential importance of this SNP or its associated SNPs.
Furthermore, the association of SNP rs1898671 with asthma was
replicated in an independent large population-based cohort.
The strength of association of rs1898671 increased when
analyzed according to smoking status. The NYUBAR excluded
individuals with .10 p-y tobacco use and so examination was
limited to those with a less than 10 p-y history of tobacco use.
Despite this, the association was strongest in the subgroup with a
history of tobacco use. The association with asthma was also
stronger in the subgroup with tobacco use in the replication
population. This finding suggests a gene-environment interaction
Table 3. Association results of haplotypes with asthma.
Haplotype Frequency Haplotype Specific OR 95% CI of OR Haplotype Specific P-value
AGAGCCAAAG 0.27 REF
GAGGGCAAAG 0.24 1.58 1.10–2.27 0.01
GGGGGCAAAG 0.16 1.12 0.75–1.68 0.57
GGGGCCAAGA 0.10 1.19 0.75–1.88 0.47
GGGGGGAAAG 0.09 0.92 0.59–1.46 0.74
GGAGCCAGAG 0.05 1.06 0.63–1.79 0.82
Rare* 0.07 1.24 0.66–2.35 0.50
*:Haplotypes with estimated frequency less than 5% are included in the rare group.
doi:10.1371/journal.pone.0025099.t003
Table 2. Results of association analysis of asthma with TSLP SNPs.
NYUBAR
dbSNP rs# Overall Ex-Smokers Never Smokers
(N=599) (N=158) (N=441)
OR 95% CI P OR 95% CI P OR 95% CI P
rs2289276 0.81 0.61–1.07 0.13 0.89 0.49–1.60 0.69 0.79 0.57–1.08 0.14
rs1898671 1.50 1.09–2.05 0.01 2.00 1.04–3.83 0.04 1.34 0.93–1.94 0.11
rs11466741 0.86 0.66–1.11 0.25 0.78 0.44–1.38 0.39 0.88 0.64–1.19 0.41
rs11466743 1.04 0.47–2.32 0.91 0.80 0.18–3.61 0.77 1.18 0.45–3.08 0.73
rs2289277 0.86 0.67–1.11 0.24 1.05 0.61–1.83 0.85 0.81 0.61–1.09 0.16
rs2289278 0.78 0.52–1.16 0.22 0.73 0.32–1.66 0.46 0.79 0.49–1.27 0.33
rs11241090 0.92 0.51–1.67 0.79 0.94 0.25–3.53 0.92 0.94 0.48–1.83 0.86
rs10035870 1.14 0.63–2.05 0.67 0.52 0.16–1.76 0.30 1.43 0.72–2.85 0.31
rs11466749 1.08 0.73–1.60 0.70 2.28 0.95–5.44 0.06 0.83 0.53–1.32 0.44
rs11466750 0.99 0.70–1.40 0.96 1.81 0.87–3.78 0.11 0.82 0.55–1.23 0.34
APCAT replication
dbSNP rs# Overall (N=18604) Ex-Smokers* (N=5872) Never Smokers* (N=8060)
rs1898671 1.15 1.07–1.23 0.0003 1.21 1.08–1.34 0.003 1.06 0.94–1.17 0.33
*: the current smoker group of the APCAT study was not shown.
doi:10.1371/journal.pone.0025099.t002
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TSLP expression and pollutants or tobacco smoke.
The rs1898671 variant is located in an intron and no functional
effect of the variant is known. However, we used a tagging
algorithm to identify tagSNPs and as such rs1898671 may be in
linkage disequilibrium with other SNPs with potential function
variation. In the HapMap CEU sample [45], rs1898671 is in
strong linkage disequilibrium (r
2=0.91) with rs1043828, which
was strongly associated with asthma in the meta-analysis by the
GABRIEL consortium (p=3.161026) [24]. Although the result
did not reach genome-wide significance in GABRIEL study, the
combination of our results with the published data now strongly
suggest that rs1898671 or a variant in LD with rs1898671
influences the susceptibility to asthma. Stratification by smoking
status was not available for rs1043828 in the GABRIEL data, so
we cannot test whether their association is also stronger in
individuals with a history of smoking. We did not perform
genotyping for SNP rs1837253 in the NYUBAR cohort but were
able to examine the association of this SNP from APCAT cohorts,
since this SNP was highlighted by He et al. [23] and the
GABRIEL study [24] as possibly associated with severe asthma.
The SNP rs1837253 was not significantly associated with asthma
risk in the overall population (OR=1.08, 95% CI: 0.99–1.17,
p=0.1), but did show a nominal association with asthma in Ex-
smokers (OR=1.22, 95% CI: 1.07–1.37, p=0.01). But this SNP is
only in weak LD with rs1898671 (r
2,0.2), and thus likely
represents a separate signal from the associations we observe.
Furthermore, the rs1898671 SNP has recently been reported in
association with increased risk of eosinophilic esophagitis when
comparing to the combined allergic and non-allergic controls [25].
Our exploratory analysis also showed a positive association of this
SNP with elevated circulating eosinophils but the result was not
statistically significant (data not shown). The possibility exists that
this SNP was not detected in other large population studies
because of the tobacco interaction.
In summary, we now suggest the association of a TSLP variant
and asthma in an admixed population after adjusting for
confounders and ancestry. We replicate the finding in an
independent population and suggest an interaction with tobacco
use. The risk for asthma was associated with a specific haplotype of
TSLP involving SNP rs1898671. These data suggest that variants
in TSLP may participate in gene and environment interactions
associated with asthma susceptibility.
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